Anti-angiogenic activity of heparin functionalised cerium oxide nanoparticles
- 1 November 2013
- journal article
- Published by Elsevier in Biomaterials
- Vol. 34 (34) , 8808-8818
Abstract
No abstract availableKeywords
Funding Information
- Australian Research Council
This publication has 55 references indexed in Scilit:
- Nanoceria: A Rare-Earth Nanoparticle as a Novel Anti-Angiogenic Therapeutic Agent in Ovarian CancerPLOS ONE, 2013
- A polyion complex micelle with heparin for growth factor delivery and uptake into cellsJournal of Materials Chemistry B, 2013
- Proteoglycans in cancer biology, tumour microenvironment and angiogenesisJournal of Cellular and Molecular Medicine, 2011
- Surface-Charge-Dependent Cell Localization and Cytotoxicity of Cerium Oxide NanoparticlesACS Nano, 2010
- Heparanase-enhanced shedding of syndecan-1 by myeloma cells promotes endothelial invasion and angiogenesisBlood, 2010
- Nanoceria exhibit redox state-dependent catalase mimetic activityChemical Communications, 2010
- Oxidase‐Like Activity of Polymer‐Coated Cerium Oxide NanoparticlesAngewandte Chemie International Edition, 2009
- Internalization and degradation of heparin is not required for stimulus of heparan sulfate proteoglycan synthesisJournal of Cellular Physiology, 2008
- Cerium and yttrium oxide nanoparticles are neuroprotectiveBiochemical and Biophysical Research Communications, 2006
- Heparan Sulfate: A Complex Polymer Charged with Biological ActivityChemical Reviews, 2005